Candriam SCA’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.87M Sell
170,522
-2,352
-1% -$122K 0.05% 266
2025
Q1
$7.36M Sell
172,874
-179,618
-51% -$7.65M 0.05% 272
2024
Q4
$10.8M Sell
352,492
-13,653
-4% -$417K 0.06% 251
2024
Q3
$8.4M Hold
366,145
0.05% 290
2024
Q2
$10.6M Sell
366,145
-99,992
-21% -$2.89M 0.06% 249
2024
Q1
$9.62M Hold
466,137
0.06% 260
2023
Q4
$12.6M Sell
466,137
-25,000
-5% -$676K 0.09% 223
2023
Q3
$14.6M Sell
491,137
-68,225
-12% -$2.02M 0.1% 185
2023
Q2
$20M Buy
559,362
+38,180
+7% +$1.37M 0.14% 156
2023
Q1
$11.2M Buy
521,182
+61,538
+13% +$1.33M 0.08% 241
2022
Q4
$12.5M Buy
459,644
+270,594
+143% +$7.36M 0.08% 228
2022
Q3
$10.2M Buy
189,050
+39,469
+26% +$2.12M 0.07% 266
2022
Q2
$6.03M Buy
149,581
+10,000
+7% +$403K 0.05% 300
2022
Q1
$9.25M Sell
139,581
-7,708
-5% -$511K 0.06% 269
2021
Q4
$14.7M Buy
147,289
+22,917
+18% +$2.29M 0.09% 210
2021
Q3
$15.5M Buy
124,372
+26,676
+27% +$3.33M 0.11% 208
2021
Q2
$12.1M Buy
97,696
+9,344
+11% +$1.16M 0.08% 261
2021
Q1
$10.9M Hold
88,352
0.09% 238
2020
Q4
$11.4M Sell
88,352
-3,986
-4% -$514K 0.09% 242
2020
Q3
$10.3M Buy
92,338
+13,751
+17% +$1.54M 0.1% 222
2020
Q2
$6.38M Buy
78,587
+20,829
+36% +$1.69M 0.07% 290
2020
Q1
$4.41M Buy
57,758
+6
+0% +$458 0.05% 383
2019
Q4
$4.51M Buy
57,752
+47,552
+466% +$3.72M 0.05% 392
2019
Q3
$651K Sell
10,200
-4,590
-31% -$293K 0.01% 660
2019
Q2
$5.49M Buy
14,790
+8,590
+139% +$3.19M 0.07% 309
2019
Q1
$476K Buy
+6,200
New +$476K 0.01% 717